Copyright: ©Author(s) 2026.
World J Diabetes. May 15, 2026; 17(5): 117237
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.117237
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.117237
Table 3 The results of subgroup analysis
| Subgroup | Number of comparisons | Participants | SMD (95%CI) | Z value | P value | Test of heterogeneity | |
| I2 (%) | P value | ||||||
| Overall | 13 | 2193 | -1.73 (-2.22 to | - | - | - | - |
| FBG | 10 | 1813 | 0 | 0.65 | |||
| 7.0-10.0 mmol/L | 8 | 1640 | -2.05 (-2.76 to | 5.7 | < 0.00001 | 97 | < 0.00001 |
| > 10.0 mmol/L | 2 | 173 | -1.87 (-2.24 to 1.49) | 9.74 | < 0.00001 | 0 | 0.46 |
| FINS | 8 | 1346 | - | - | - | 0 | 0.71 |
| ≤ 10 μU/mL | 4 | 826 | -2.17 (-3.24 to | 3.99 | < 0.00001 | 97 | < 0.00001 |
| > 10 μU/mL | 4 | 520 | -2.42 (-3.21 to | 6.01 | < 0.00001 | 90 | < 0.00001 |
| HOMA-IR | 9 | 1644 | - | - | - | 78.5 | 0.03 |
| ≥ 3.0 | 7 | 1330 | -2.37 (-3.10 to | 6.35 | < 0.00001 | 96 | < 0.00001 |
| < 3.0 | 2 | 314 | -1.47 (-1.84 to 1.10) | 7.78 | < 0.00001 | 38 | 0.21 |
| HbA1c | 10 | 1581 | - | - | - | 0 | 0.56 |
| < 8.0% | 4 | 619 | -1.50 (-2.18 to | 4.31 | < 0.00001 | 90 | < 0.00001 |
| ≥ 8.0% | 6 | 962 | -1.79 (-2.45 to | 5.26 | < 0.00001 | 94 | < 0.00001 |
| Age | 9 | 1667 | - | - | - | 7.2 | 0.3 |
| ≤ 55 | 5 | 862 | -2.08 (-2.99 to | 4.48 | < 0.00001 | 96 | < 0.00001 |
| > 55 | 4 | 805 | -1.50 (-2.12 to | 4.69 | < 0.00001 | 93 | < 0.00001 |
| BMI | 10 | 1813 | - | - | - | 91.6 | < 0.00001 |
| Normal | 1 | 298 | -1.26 (-1.52 to | 9.44 | < 0.00001 | - | - |
| Overweight | 8 | 1455 | -1.98 (-2.68 to | 5.5 | < 0.00001 | 96 | < 0.00001 |
| Obese | 1 | 60 | -3.24 (-4.02 to | 8.09 | - | - | - |
| TG | 10 | 1813 | - | - | - | 60.6 | 0.11 |
| < 1.7 mmol/L | 3 | 632 | -2.77 (-4.08 to | 4.16 | < 0.00001 | 97 | < 0.00001 |
| ≥ 1.7 mmol/L | 7 | 1181 | -1.65 (-2.11 to | 7.01 | < 0.00001 | 90 | < 0.00001 |
| TC | 10 | 1813 | - | - | - | 0 | 0.39 |
| < 5.2 mmol/L | 7 | 1172 | -2.20 (-2.88 to | 6.30 | < 0.00001 | 94 | < 0.00001 |
| ≥ 5.2 mmol/L | 3 | 641 | -1.60 (-2.77 to | 2.68 | < 0.00001 | 97 | < 0.00001 |
| LDL-C | 9 | 1723 | - | - | - | 0 | 0.69 |
| < 3 mmol/L | 5 | 820 | -1.85 (-2.30 to | 8.17 | < 0.00001 | 81 | < 0.00001 |
| ≥ 3 mmol/L | 4 | 903 | -2.14 (-3.51 to | 3.06 | < 0.00001 | 98 | 0.002 |
| HDL-C | 10 | 1813 | - | - | - | 62 | 0.10 |
| < 1.0 mmol/L | 2 | 381 | -1.43 (-1.88 to | 6.30 | < 0.00001 | 59 | < 0.00001 |
| ≥ 1.0 mmol/L | 8 | 1432 | -2.15 (-2.90 to | 5.65 | < 0.00001 | 96 | < 0.00001 |
| Year | 13 | 2193 | - | - | - | 71.7 | 0.06 |
| ≤ 2020 | 6 | 838 | -2.38 (-3.49 to | 4.18 | < 0.00001 | 97 | < 0.00001 |
| > 2020 | 7 | 1355 | -1.27 (-1.55 to | 8.95 | < 0.00001 | 76 | < 0.00001 |
| Race | 13 | 2193 | - | - | - | 0 | 0.61 |
| Chinese | 10 | 2031 | -1.84 (-2.36 to | 6.82 | < 0.00001 | 95 | < 0.00001 |
| Non-Chinese | 3 | 162 | -1.37 (-3.06 to | 1.59 | 0.11 | 94 | < 0.00001 |
- Citation: Chen L, Gao CB, Duan Q, Shi G, Niu QS. Association between circulating CTRP12 levels and type 2 diabetes: A meta-analysis. World J Diabetes 2026; 17(5): 117237
- URL: https://www.wjgnet.com/1948-9358/full/v17/i5/117237.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i5.117237